Cosentyx (secukinumab) - Novartis
Cosentyx: Regulatory submission for nrAxSpA in 2019 (Novartis) - Jul 18, 2019 - Q2 2019 Results: Regulatory submission for psoriatic arthritis in 2020 
Regulatory
https://www.novartis.com/sites/www.novartis.com/files/q2-2019-ir-presentation.pdf
 
Jul 18, 2019
 
 
b1c2bfcf-82ad-4f00-96f5-b9877a3c50d3.jpg